way in the infected organism, depending on the type and level of differentiation of the host cell. The switch between latency and lytic replication was previously shown, for Burkitt's lymphoma cell lines, to depend on the viral BZLF1 gene product. Protein-DNA assays were used to identify the cis-acting elements that represent the link between regulating signal transduction pathways and the viral cascade of gene expression. confirmed that these sites act as specific protein recognition sites. Using a set of reporter plasmids we were able to demonstrate a negative regulatory effect of the HI motif in some B lymphoid cell lines, in contrast to epithelial HeLa cells. The HI silencer elements are different from other silencer elements described so far in respect of their sequence and protein-binding pattern during the activation of BZLF1.
Introduction
Cell type-specific regulation of latency and productive lytic replication is important for the lifelong persistence of Epstein-Barr virus (EBV) after primary infection. A small proportion of lymphocytes from healthy donors contain latently replicating EBV genomes. However, the cell cycle-independent replication of viral DNA and death of the infected cell, as a consequence of a lytic cycle of virus replication, is a rare event. In epithelial tissues of the uterine cervix, parotid gland and tongue (Wolf et al., 1984; Sixbey et al., 1986; Greenspan et al., 1985; Becker et al., 1991; Young et al., 1991) , the virus replicates and consequently lyses the host cell. The product of the viral reading frame BZLFt (Z'ta, EB1, ZEBRA) disrupts latency in Burkitt's lymphoma (BL) cells and leads to viral replication in distinct cell types (Countryman et al., 1987; Bogedain et al., 1994) . Z'ta trans-activates a series of homologous and heterologous early viral promoters (Chavrier et al., 1989; ChevallierGreco et al., 1986 ChevallierGreco et al., , 1989 Cox et al., 1990; Kenney et al., 1989a, b; Lieberman et al., 1990; Rooney et al., 1989) and the other immediate early genes BRLF1 (ChevallierGreco et al., 1989) and BI'LF14 , as well as the BZLF1 promoter itself (Urier et al., 1989; Flemington & Speck, 1990b) . Hence Z'ta has a pivotal role in the transition from latency to lytic replication. Control of transcriptional activity by positively as well as negatively acting elements has been shown (Flemington & Speck, 1990a; Montalvo et al., 1991) . In order to identify cis-acting elements that mediate the control of ~ BZLF1 gene induction by the host, we employed DNA binding assays with protein extracts from cells that were latently infected and from cells permitting lytic replication of EBV. We identified elements that changed their pattern of protein binding during gene activation. These elements, with a common sequence motif, designated HI, were repeated five times (~, fl, ~, 6 and e) within the promoter region of the BZLF1 gene. Sitedirected mutagenesis and transfection assays with reporter constructs demonstrated their functional impor-tance for down-regulation of BZLF1 during latent infection.
Methods
Cell lines and transfection assays. For transfection assays we used the lymphoid EBV-negative BL cell line B JAB, the EBV-positive BL cell line Raji, two lymphoid cell lines (LCL), established by spontaneous outgrowth (Ru-LCL and Em-LCL) and epithehal HeLa cells. Transfection of lymphoid cells was achieved by electroporation with a BioRad Gene Pulser. Cells (2 x 107) were collected by centrifugation at 1000g at room temperature~ washed once and resuspended in 400 lal PBS. The cells were mixed with 100 lal of DNA solution (50 lag of plasmid DNA in PBS) and incubated for 10rain at room temperature. The cells were treated with a pulse of 250 V/960 laF, incubated for another 10rain at room temperature and finally resuspended in 5 ml RPMI with 10 % fetal calf serum. After 3 to 5 days, the culture medium was tested for the presence of the reporter protein hepatitis B virus surface antigen (HBsAg; Marschall et al., 1989) . The epithelial cell line HeLa was transfected by calcium phosphate precipitation as described earlier (Marschall et al., 1989) . Promoter activities were expressed as percentage activity (the average of at least three independent experiments) in relation to a control construct which did not contain EBV inserts.
Recombinantplasmids andoligonucleotides. The recombinant plasmid pEBZ contains the complete promoter region of BZLFI (Baer et al., 1984; Skate & Strominger, 1980) , from the BamHl site at position -551 to the NaeI site at position +13 (relative to the start site of transcription). The plasmid was constructed by inserting the 564 bp BamHI-NaeI fragment into pUC18 BamHIHincII sites. The pEBZ EBV insert was subcloned further, in three fragments, for bandshift assays. The proximal 240 bp SphI-SphI fragment was cloned into the pUC18 SphI-SphI site, the central 120 bp SphI-BalI fragment was cloned into pUCI8 HincII-SphI and the distal 200 bp BalI-BamHI fragment into pUC18 BamH1-HincI1. This gave the constructs pZ240, pZl20 and pZ200 respectively (Fig. 1) . The promoter region from positions -551 to -227, relative to the start site of transcription, was inserted upstream of the heterologous early enhancer-promoter of simian virus 40 (SV40), which drives the expression of HBsAg in the plasmid pSVHBs (Marschall et aL, 1989) . The BamHI-SphI fragment of the promoter was treated with T4 DNA polymerase and cloned into the EcoRI site of pSVHBs, which had been blunt-ended with the Klenow fragment of DNA polymerase, to give pSSVHBs.
Point mutations were introduced into the BZLF1 promoter region using modifications of the PCR techniques reviewed by Higuchi (1990) . The sites targeted for mutagenesis were the HI c~, fl and 7 sequence motifs, identified in the promoter region using the GCG software package (Devereux et aL, 1984) . The sequences of each of the five motifs are shown in Fig. 2 (a) . The mutations (indicated in bold), which effectively inactivate individual motifs from the promoter, resulted in a sequence of 5' TAAGCTTG 3" for the HI ~ element, 5" CAAGATTG 3" for HI fl and 5' CAAGCTTG 3" for HI ?. The PCR-mutagenesis products, designated ~*, fl* and 7', were cut with the restriction
BamHI
Bali S~hI NaeI promoter. The resulting constructs, pSSVHBs~*, pSSVHBsfl*, pSSVHBsy* and pSSVHBsc~* +fl*, contained one or two defective HI motifs (Fig. 2b) . All recombinant reporter plasmids were sequenced with an Applied Biosystems automatic sequencer. The HI 6 sequence motif was used as a probe in several experiments. The motif was incorporated into the central region of a doublestranded oligonucleotide, oligo-Z120HI. This oligonucleotide was created by annealing two complementary single-stranded sequences, Labelling of DNA fragments and oligonucleotides. For band shift assays, the subcloned DNA fragments were excised from the recombinant plasmids with the restriction enzymes BamHI and HindIII, purified by agarose gel electrophoresis and end-labelled with [7-32P]ATP and T4 polynucleotide kinase (5' end-labelling kit, Boehringer Mannheim). For footprint assays the recombinant plasmids were linearized at one restriction site, dephosphorylated with calf intestinal phosphatase and end-labelled with [7-32P]ATP. The T4 polynucleotide kinase was then inactivated by heat and the insert was excised with a second restriction enzyme, to yield an asymmetrically Y-end-labelled fragment, which was then purified by agarose gel electrophoresis.
5" GATCCACTAGAGTCCATGACAGAGGATTTGAATCTGG-
Nuclear extracts. These were prepared by a modification of the procedure described by Dignam et al. (1983) . Cells (108) were harvested by centrifugation (600 g for 10 min at 4 °C), washed twice with PBS, resuspended in 5 packed-cell volumes of buffer I (10 mM-HEPES, 1 mM-MgC12, 10 mM-KC1, 0"5 mM-DTT, 0.5 mM-PMSF pH 7"9) and incubated on ice for 5 rain. Thereafter the nuclei were prepared by a few strokes with an all-glass Dounce homogenizer, monitored by microscopy. The nuclei were washed three times in buffer I (100 g for 10 min at 4 °C), the pellet was resuspended in 300 ~tl buffer II (20 mM-HEPES, 25% glycerol, 420 mM-NaC1, 1-5 mM-MgCI~, 0.5 mM-PMSF, 0-5mM-DTT) and the proteins eluted for 30rain on ice. The supernatant was clarified by centrifugation (25000 g for 30 min at 4 °C) and aliquots were stored at -80 °C. Further purification and fractionation of the protein extracts was achieved by chromatography. DNA-binding proteins were enriched on a heparin-agarose column (Sigma) and fractionated further on an ion-exchange column (S Sepharose HP, Pharmacia).
DNA-protein binding assays. Frozen nuclear protein extracts were diluted with binding buffer without NaC1 (50 mM-HEPES pH 7.9, 1 mM-EDTA, 1.5 mM-MgC12, 5 mM-DTT, 10% glycerol) to the optimum NaCI concentration of 200 mM. In band shift assays, 2 to 5 ~tg of nuclear proteins were preincubated for 30 rain, in binding buffer containing 150 mM-NaCI to a volume of 24 ~tl, with 2-0 ~tg of dAdT to reduce non-specific binding of proteins and with increasing concentrations of specific competitor DNA. Next, 1 ng (approximately 8 fmol) of 3Zp-labelled probe was added and incubated for 15 min. After electrophoresis in a 4 % polyacrylamide gel, the DNA was visualized by autoradiography. For footprint assays 2 x 104 c.p.m. (Cerenkov counts) of asymmetrically 32p-end-labelled DNA was incubated with increasing concentrations of protein, to a volume of 38 ~tl, using the same conditions as for gel retardation. Then 2 ~tl of 0.1 M-MgCI~ and 175 units of exonuclease III (Boehringer Mannheim) were added and incubated for 10 min at 37 °C so that the DNA fragments were digested unidirectionally, starting at their 3' ends. Proteins bound to DNA caused the enzyme to stop, yielding DNA fragments with distinct sizes relative to the 5' label (Hennighausen & Lubon, 1987) . The reaction was stopped with 150 pl of 0.5 % Sarcosyl, 10 mM-EDTA, 0.4 M-NaC1, 2.5 ~tg/pl glycogen, extracted once with phenol-chloroform-isoamyl alcohol, precipitated with ethanol and separated by electrophoresis in a 6% sequencing gel in 0.5 × TBE.
Results

Proteins bind specifically during latent replication to the distal promoter of BZLF1
C o n t r o l of B Z L F 1 gene transcription is one possible way to control viral replication. It has been shown earlier that negative ( M o n t a l v o et al., 1991) as well as positive ( F l e m i n g t o n & Speck, 1990a, b) regulatory elements control the activity of this gene. We compared binding of protein in the regulatory region of BZLF1 in latently infected cells and cells permissive for lytic replication. To visualize specific b i n d i n g of regulatory factors, the region from -5 5 1 to + 1 3 , relative to the start of the transcription, was subcloned in three fragments which were designated Z200 (distal region), Z120 (central region) and Z240 (most proximal region), according to their length in bp, (Fig. 1 ). Fig. 3 shows the f o r m a t i o n of several p r o t e i n -D N A complexes after i n c u b a t i o n of these p r o m o t e r fragments with crude nuclear extracts. 4 and 11) . The specific complexes with fragments Z120 and Z200 did n o t form with protein extracts from T P Atreated cells (lanes 7 and 14) . The most proximal fragment Z240 also showed specific p r o t e i n -D N A complexes but these complexes were unaltered after T P 14) . Use of nuclear extracts from unstimulated or TPA-stimulated Raji cells, as well as specific (Z120 and Z200) or non-specific (pUC18) competition, is indicated above the respective lanes. promoter region of BZLF1, indicating a functional role for the down-regulation of this promoter during latency.
The site that mediates specific binding of protein during latency & multiply repeated in the promoter of BZLF1
Band shift competition experiments with the three subfragments showed that all three would compete for specific complex formation. This was in contrast to competition with pUC18 DNA (data not shown), suggesting a binding site for the protein is present on each of these fragments. Sequence analysis of the promoter region using GCG software (Devereux et al., 1984) detected a multiply repeated sequence. This motif, designated the HI element, with the consensus sequence 5' ACAGA(T/G)G(A/G)3' was found three times in region Z200, once in region Z240 and once in Z120 (Fig.  4 and Fig. 2 a) . Footprint experiments were performed to test whether these sites were occupied by proteins in latently infected cells. In agreement with another report (Montalvo et al., 1991) , no clear footprinting was possible in this region using crude nuclear extracts.
Exonuclease III footprints were therefore employed. These are much more sensitive than DNase I assays (Vogel et al., 1989) because each bound protein molecule theoretically yields a positive signal. The results of the footprint assays are depicted in Fig. 5 , in relation to the location of the HI sequences identified by computer analysis. Using increasing concentrations of protein, binding was detected at various distances from the 3' end of the DNA. On each of the fragments used in band shift assays, proteins bound to one HI sequence. These sites specifically bound proteins from unstimulated lymphocytes and have been described, in part, previously (Flemington & Speck, 1990a, b) . Indeed, the HI motif did function as a specific binding site, and in latently infected Raji cells three (~, 6 and e) of the five elements were bound by protein.
To confirm that the HI elements were involved in the formation of TPA-sensitive protein-DNA complexes, protein fractions from unstimulated and TPA-stimulated Raji cells were tested for the ability to bind to the HI sequence motif using the probe oligo-Z120HI. Crude nuclear extracts were divided into two fractions by The regions between exonuclease III stops, which are bound by proteins, are depicted as bars. ZI, ZII and ZIII are regulatory elements described previously (Flemington & Speck, 1990a, b) .
heparin-agarose and ion exchange column chromatography. Fig. 6 shows that in latently infected cells only (lanes 1 and 2) a protein in fraction I bound to the HI motif, but did not bind after TPA treatment (lane 3), nor to the larger fragment Z120 (lane 6). In fraction II however, there were proteins that bound to the larger Z120 fragment after TPA stimulation (lanes 7 and 8) but did not bind to the HI motif (lanes 4 and 5).
H I elements act as negative regulatory silencer elements
As the pattern of protein binding points towards a silencing mechanism during latency, we constructed reporter plasmids with site-specific mutations in the HI motif to investigate their regulatory influence. The results are shown in Table 1 . When the intact region from positions -551 to -2 2 7 was tested upstream of the heterologous enhancer-promoter in the EBV-negative B JAB cell line, a 60 % decrease in promoter activity was observed.
In none of the other tested cell lines was a comparable influence detected. Each of the four mutations abolished the negative regulatory effect, suggesting a contribution of each of the destroyed elements to the silencing function in this cell line. Interestingly, mutations fl*, y* and ~* +fl* not only abolished the negative regulation, but increased the promoter activity from 40 to 144% (relative to the control) in BJAB cells. Similar results were observed for the Raji cell line, where mutation of the HI elements fl, y and ~ plus fl reproducibly increased the promoter activity to about 160%. Raji cells showed no repression of activity with the intact distal region; a mutation in the ~ HI element had no influence and activity remained at 100% of the control. With the two LCLs however, strong activation occurred with mutation fl* and ~*, of up to 217 % in Ru-LCL and up to 302% in Em-LCL. The ~* mutation resulted in the strongest enhancement of promoter activity (up to 280 % in Ru-LCL and 760 % in Em-LCL) and there was no negative effect of the unmutated distal
region. These results demonstrate that the H I elements are negative regulatory silencing elements under appropriate conditions, depending on the indivdiual cell line and also confirm the presence of positive regulatory elements located in the promoter region between positions -2 2 7 and -5 5 1 , described earlier by Montalvo et al. (1991) . In H e L a cell line, neither an effect of the intact distal promoter nor of the different H I mutations could be measured.
D i s c u s s i o n
We have identified a sequence motif, HI, that is repeated five times in the promoter region of BZLF1 (Fig. 4) . Band shift assays with specific oligonucleotides and exonuclease III footprints showed that there are cellular proteins in latently EBV-infected lymphoid cells that bind to the H I motif. In the distal region of the promoter (Z 120 and Z200) these sites showed loss of bound protein following TPA treatment, indicating a role in repression of the BZLF1 promoter during latency. Cloning of the distal promoter, from positions -5 5 1 to -2 2 7 , in front of the heterologous SV40 enhancer-promoter in a reporter plasmid and in vitro mutagenesis of individual HI elements showed that the H I elements confer a negative regulatory influence on the downstream promoter. Flemington & Speck (1990a) have shown that the proximal region of the promoter, but not the distal region, contains regulatory elements that directly respond to TPA in EBV-negative cell lines and that are directly involved in promoter activation. However, they could not identify the H I silencer elements which downregulate stimulatory elements nearby. This H I mechanism is cell line-dependent and functions only very poorly in EBV-negative lymphoid B JAB cells and in EBV-positive Raji cells, and not at all in epithelial HeLa cells. After TPA treatment the HI elements lose their negative regulatory effect. We assayed HI function by inactivation of these elements without TPA stimulation of the cells and thereby demonstrated H I activity during Flemington & Speck (1990 a) , the target elements that are suppressed by the HI motifs are not directly stimulated by TPA. TPA sensitivity concerns silencer inactivation but not induction of the positive elements, which seem to be regulated in a TPA-independent way. In the EBVnegative B JAB cell line, the presence of the intact distal promoter, from position -227 to -551, decreased activity of the SV40 enhancer-promoter to about 40 %.
In all other cell lines tested, whether lymphoid or epithelial, no silencing function of the intact distal upstream region was observed. A likely explanation for this difference is the weak activity of positive control elements in B JAB cells, which results in a stronger suppression by the silencer elements. The model of a negative and a positive regulatory module also explains the results obtained in Raji cells. In these cells we could demonstrate binding of protein to the HI sequences (Fig.  3 ), but inactivation of these sites had only a slight effect on the activity of a downstream promoter (Table 1) because the positive regulatory target elements were inactive. Experiments to identify the trans-acting cellular proteins that interact with these positive and negative regulatory cis-acting elements are in progress. The HI elements ~, fl and 7 are different from some of the negative regulatory elements located in the proximal region of the promoter from -227 to + 13 described by Flemington & Speck (1990a) . They also differ from a 48 bp silencer described by Montalvo et al. (1991) . Fig. 7 shows the HI elements ]~ and y in relation to the 48 bp silencer. The inverted repeat sequences on the right side of the 48 bp silencer are identical to the HI fl and y but there are two important properties of HI that distinguishes the two silencers. Firstly, mutation of the most distal HI element, e, blocks the observed silencer . Schematic drawing of the distal promoter of BZLF1. The area containing the 48 bp silencer element described previously (Montalvo et al., 1991) partially overlaps with the HI elements, but they are not functionally identical. Regions I and II are protein-bound elements of the silencer region described earlier (Montalvo et al., 1991) as are the inverted repeats, indicated by arrows, which are important for activity. SRE denotes a serum response element overlapping region II, the right inverted repeat pair and one HI element. In conclusion, we have identified a new type of silencing sequence motif, HI, in the promoter of the BZLF 1 gene, which is involved in the down-regulation of this lytic trans-activator in latently infected lymphoid cells. The proximity of the HI motif to other protein binding regions, identified by footprinting, and to binding motifs for other regulatory cellular factors like YY1 (Seto et al., 1991) , SRE (Gualberto et al., 1992; Treisman, 1986) and AP1 (Rauscher et al., 1988) suggests that the HI binding factor works through proteinprotein interactions or by steric hindrance exerted on binding sites in the proximity.
